Skip to content

Cerus CERS Interest Expense

Interest Expense at other companies

Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$12.3M+2.5%
QuidelOrtho Corporation logo
QuidelOrtho CorporationQDEL
$51.1M+27.8%
ADMA Biologics logo
ADMA BiologicsADMA
$2.1M+6.3%

Other financials

Income statement

See full
Revenue$53.7M+24.1%
Operating income-$354.0K+94.0%
Net income-$1.6M+78.7%
EPS (diluted)-$0.01+75.0%

Balance sheet

See full
Cash & equivalents$27.9M+43.0%
Total debt$45.0M-43.3%
Total equity$67.6M+21.7%
Total assets$222.9M+7.8%

Cash flow

See full
Operating cash flow-$3.0M-261%
CapEx$233.0K+108%
Free cash flow-$3.3M-243%

Valuation

See full
Market cap$573.06M+124%
Enterprise value$590.17M+86.7%
P/S2.9×-1.0×

Profitability

See full
Gross margin64%
Operating margin-6.2%-2.1pp
Net margin-9.8%-2.8pp
FCF margin3.5%+1.9pp

Returns & leverage

See full
Return on equity-15.5%-5.6pp
Debt / equity0.7×-0.8×
Current ratio1.6×-0.7×

Where this comes from

Reported directly by Cerus in its filing.

Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.

The official record: Cerus’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cerus's interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cerus's interest expense?
Cerus (CERS) reported interest expense of $1.87M in Q1 2026.
How has Cerus's interest expense changed year-over-year?
Cerus's interest expense decreased by 11.3% year-over-year, from $2.11M to $1.87M.
What is the long-term trend for Cerus's interest expense?
Over 4 years (2021 to 2025), Cerus's interest expense has grown at a 14.1% compound annual growth rate (CAGR), from $4.92M to $8.34M.
What does interest expense mean?
Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.